Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
72 /100
HIGH RISK
Score updated Oct 13, 2026

LTRN — Lantern Pharma Inc. Dilution Risk Tracker

Track LTRN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LTRN — Get alerts when the score changes →

As of October 13, 2026, Lantern Pharma Inc. (LTRN) has a DilutionWatch DilutionScore of 72/100, rated HIGH dilution risk. Lantern Pharma Inc. has a market capitalization of $9.42M, 12.78M shares outstanding, 32 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
85
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 24%
💰 Capital Raise model 35%
• Low cash runway: 6 months remaining
🔄 Reverse Split model est. 15%
• Only 6 months cash — financial pressure
📉 Score Deterioration model 10%
• Score in HIGH risk zone (72/100)
🔔 Track LTRN — Get forecast alerts →

Market Data

Market Cap$9.42M
Shares Outstanding12.78M
Float8.61M
Cash$7.36M
Debt$59.1K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore72/100DilutionWatch score record
Shares Outstanding12.78MVerified float table or market cache
Public Float8.61MVerified float table or market cache
Market Cap$9.42MMarket data cache
Cash Runway5.9 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 2.8% shares (2026Q1 vs prior)
32 institutional holders · 2.40M shares
#1 BIOS Capital Management, LP 864.4K shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 664.2K shares
#3 CM Management, LLC 250.0K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest485.8K
Days to Cover1.3
% of Float5.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-14
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual LTRN Dilution Snapshot

Lantern Pharma Inc. (LTRN) has a DilutionScore of 72/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

LTRN's DilutionScore is currently 72/100 (High risk), with 3 score changes tracked over 89 days. The score improved from 56/100 (High risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202672/100HIGH13 days
Aug 22 – Sep 30, 202656/100HIGH40 days
Aug 14 – Aug 21, 202661/100HIGH7 days
Jul 16 – Aug 13, 202657/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

LTRN shares outstanding have increased 13.4% from 11.25M (Apr 2026) to 12.76M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 17, 202612.76M8.61M▲ 0.44%
Apr 20, 202611.25M8.57M▲ 1.49%
Apr 13, 202611.25M8.44M▼ 1.75%
Apr 10, 202611.25M8.59M▼ 1.95%
Apr 07, 202611.25M8.76M▲ 0.06%
Apr 01, 202611.25M8.76M▲ 0.63%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track LTRN Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment LTRN files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking LTRN — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for LTRN
LTRN FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.